Cargando…

Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study

Erythrodermic psoriasis (EP) is a dermatological emergency and its treatment with secukinumab is still controversial. Furthermore, no data exist regarding the prognostic value of drug abuse in such a condition. We performed a multi-center, international, retrospective study, enrolling a sample of EP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damiani, Giovanni, Pacifico, Alessia, Russo, Filomena, Pigatto, Paolo Daniele Maria, Bragazzi, Nicola Luigi, Bonifati, Claudio, Morrone, Aldo, Watad, Abdulla, Adawi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617329/ https://www.ncbi.nlm.nih.gov/pubmed/31159169 http://dx.doi.org/10.3390/jcm8060770

Ejemplares similares

The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter Study
por: Damiani, Giovanni, et al.
Publicado: (2019)

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching
por: Damiani, Giovanni, et al.
Publicado: (2022)

The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study
por: Adawi, Mohammad, et al.
Publicado: (2019)

The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting (“Ramadan Fasting”) on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study
por: Damiani, Giovanni, et al.
Publicado: (2019)

Sex-Based Medicine Meets Psoriatic Arthritis: Lessons Learned and to Learn
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2022)

Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report
por: Lu, Jiajing, et al.
Publicado: (2020)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023)

Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature
por: Bragazzi, Nicola Luigi, et al.
Publicado: (2022)

Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review
por: Salem, Iman, et al.
Publicado: (2019)

Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
por: Carriero, Martino
Publicado: (2022)

Forecasting the West Nile Virus in the United States: An Extensive Novel Data Streams–Based Time Series Analysis and Structural Equation Modeling of Related Digital Searching Behavior
por: Watad, Abdulla, et al.
Publicado: (2019)

Discrepancies Between Classic and Digital Epidemiology in Searching for the Mayaro Virus: Preliminary Qualitative and Quantitative Analysis of Google Trends
por: Adawi, Mohammad, et al.
Publicado: (2017)

Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study
por: Pacifico, Alessia, et al.
Publicado: (2021)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Secukinumab in Erythrodermic Psoriasis: Real World Experience of 6 Patients Successfully Treated by Injecting at Unconventional Sites
por: Panda, Maitreyee, et al.
Publicado: (2021)

A Review of the Use of Secukinumab for Psoriatic Arthritis
por: Patel, Nupur U., et al.
Publicado: (2017)

Correction to: Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

Nanotechnology meets atopic dermatitis: Current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature
por: Damiani, Giovanni, et al.
Publicado: (2019)

Folate and B12 Levels Correlate with Histological Severity in NASH Patients
por: Mahamid, Mahmud, et al.
Publicado: (2018)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Changes in metabolic parameters in psoriatic patients treated with secukinumab
por: Wang, Hsuan Ning, et al.
Publicado: (2020)

Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis
por: Kirby, Colm, et al.
Publicado: (2021)

Readability of Wikipedia Pages on Autoimmune Disorders: Systematic Quantitative Assessment
por: Watad, Abdulla, et al.
Publicado: (2017)

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017)

Gut microbiota and nutrient interactions with skin in psoriasis: A comprehensive review of animal and human studies
por: Damiani, Giovanni, et al.
Publicado: (2020)

Editorial: Early Origins of Psoriatic Arthritis
por: Simon, David, et al.
Publicado: (2021)

FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study
por: Watad, Abdulla, et al.
Publicado: (2019)

Searching the Internet for psychiatric disorders among Arab and Jewish Israelis: insights from a comprehensive infodemiological survey
por: Adawi, Mohammad, et al.
Publicado: (2018)

Systemic Sclerosis Is Linked to Psoriasis and May Impact on Patients’ Survival: A Large Cohort Study
por: Watad, Abdulla, et al.
Publicado: (2019)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Hidradenitis suppurativa associated with systemic lupus erythematosus: A case report
por: Ben David, Chen, et al.
Publicado: (2018)

Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
por: Damiani, Giovanni, et al.
Publicado: (2018)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
por: Buchanan, Vanessa, et al.
Publicado: (2018)

Translation and Validation of the Nomophobia Questionnaire in the Italian Language: Exploratory Factor Analysis
por: Adawi, Mohammad, et al.
Publicado: (2018)

Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy
por: Santus, Pierachille, et al.
Publicado: (2018)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k4u2tb2i7j7bc2laossjq70hc8